Leading Healthcare Companies Scheduled to Present NEW YORK, Jan. 22 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today announced...
Merck & Co., Inc. (NYSE: MRK) and Idera Pharmaceuticals (AMEX: IDP) announced today that they have formed a broad collaboration...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company?s...
Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like...
Idera Pharmaceuticals (AMEX: IDP) today presented data for a novel class of compounds which act as antagonists of specific...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that on November 6, 2006 it will sell 781,250 shares of its common stock...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced the issuance of US patent 7,115,579 (the ?579 patent) for a method of...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced the issuance of US patent 7,105,495 (the '495 patent) for immune modulatory...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that Robert Karr, M.D., President of Idera, will discuss the Company's TLR-targeted drug...
Idera Pharmaceuticals (AMEX: IDP) today announced the formation of its Oncology Clinical Advisory Board (OCAB). Idera's OCAB is comprised of an...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced the granting of patents in Europe (EU 1,278,761) and Australia (AU 2001257366) on immune...
Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced that on July 24, 2006 it will sell 683,594 shares of its common stock at a price of $5.12...
Idera Pharmaceuticals (AMEX: IDP) announced today that its previously declared one-for-eight reverse stock split became effective at the close of...
Idera Pharmaceuticals (AMEX: IDP) today announced that its Board of Directors has authorized a one-for-eight reverse split of the Company's common...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.